Purpose The hypothesis that covered stents are superior to bare-metal stents (BMS) in long
femoropopliteal artery disease was tested. The one-year results of the VIASTAR trial …

Objectives: The hypothesis that endovascular treatment with covered stents has equal risks
but higher efficacy than bare-metal stents (BMS) in long femoropopliteal artery disease was …

Background: A clear patency benefit of a drug-eluting stent (DES) over bare metal stents
(BMSs) for treating peripheral artery disease of the femoropopliteal segment has not been …

Purpose: To investigate the 5-year outcome of patients treated with self-expanding covered
stents for superficial femoral artery (SFA) occlusive disease and identify parameters that …

Background Endovascular treatment of femoropopliteal artery disease has shifted toward
drug-coated balloons (DCB). However, limited data are available regarding the safety and …

Background: Drug-eluting technologies improve 12-month angiographic results of
femoropopliteal (FP) interventions, but few data on the comparison between drug-coated …

Aims: To examine the efficacy and durability of an interwoven self-expanding nitinol stent in
the treatment of complex femoropopliteal artery lesions in unselected patients. Methods and …

Background—Sustained benefits of drug-eluting stents in femoropopliteal arteries have not
been demonstrated. This prospective, multinational, randomized study was designed to …

Purpose: To evaluate outcomes of covered vs bare metal stents for the treatment of lower
limb peripheral artery disease. Methods: A search of electronic databases was performed to …

Objectives The primary objective of the BATTLE (Bare Metal Stent vs. Paclitaxel Eluting
Stent in the Setting of Primary Stenting of Intermediate-Length Femoropopliteal Lesions) trial …